Argonautica Private Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Argonautica Private Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$627K	Buy	+1,191	New	+$668K	0.15%	115

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Argonautica Private Wealth Management's IDXX Position: Q2 2026 in Review

Argonautica Private Wealth Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1,191 shares worth $627K. The stake represents 0.15% of the portfolio and ranks #115 among its holdings.

1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Argonautica Private Wealth Management held 1,191 shares of Idexx Laboratories worth $627K as of Q2 2026.
Idexx Laboratories was a new Argonautica Private Wealth Management position in Q2 2026.
Idexx Laboratories made up 0.15% of Argonautica Private Wealth Management's portfolio in Q2 2026, its #115 holding.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.